
The first devices are expected later this year
By Shawn Knight,
Why it matters: Paired with Google's reworked Wear OS, Android
smartwatches powered by Qualcomm's new Snapdragon Wear 3100 have their
best opportunity to date to gain meaningful market share.
Qualcomm earlier this summer announced the Snapdragon Wear 2500, a
mid-range SoC designed specifically for smartwatches for kids. Now, the
company’s primary wearable platform, the Snapdragon Wear 2100, is
getting a much-needed refresh.
Originally launched in early 2016, the Snapdragon Wear 2100 has since
been upstaged by offerings from Apple and Samsung. Qualcomm levels the
playing field today with the introduction of the Snapdragon Wear 3100.
The company’s latest packs four A7 cores, a digital signal processor and
an ultra-low-power co-processor in a configuration Qualcomm calls
big-small-tiny. The A7 cores handle intensive tasks like app switching
while the two smaller chips tackle background chores, monitor sensors
and so on.
By allocating jobs to the best hardware for the task, Qualcomm says
smartwatches based on the Snapdragon Wear 3100 will exhibit much better
battery life. Real-world results will vary based on device and usage but
on average, users can expect anywhere between four to 12 hours of
additional runtime compared to Wear 2100-equipped devices.
Qualcomm also worked with Google to develop three new operating modes to
promote better battery life. Enhanced ambient mode shows a basic watch
face UI with a moving second hand, improved brightness and live
complications (any function beyond telling time). Traditional watch
mode, meanwhile, foregoes those bells and whistles in favor of simply
telling the time while a dedicated sports mode – set to arrive
post-launch with a “sports customer” – will enable up to 15 hours of GPS
and heart-rate tracking.
Qualcomm’s first Snapdragon Wear 3100 customers include Fossil Group,
Louis Vuitton and Montblanc. The first devices powered by the new
platform are expected in Q4 2018.
https://www.geezgo.com/sps/38722
Comments
Post a Comment